Education
About Us
Working with TipRanks
Follow Us
STXD - ETF AI Analysis
Top Page
Strive 1000 Dividend Growth ETF (STXD)
Rating:73Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several key holdings, such as Broadcom, Microsoft, and Oracle, have delivered strong year-to-date performance, supporting the ETF’s overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Technology, Financials, and Health Care, reducing reliance on any single industry.
Reasonable Expense Ratio
With an expense ratio of 0.35%, the fund offers a cost-effective option compared to many actively managed ETFs.
Negative Factors
High U.S. Concentration
The ETF is heavily focused on U.S. companies, with over 99% geographic exposure, limiting diversification across global markets.
Underperforming Holdings
Some holdings, like Home Depot and Eli Lilly, have shown weak or minimal gains, which could drag on overall performance.
Technology Overweight
With over 26% of the portfolio in Technology, the ETF is vulnerable to downturns in this sector.
STXD vs. SPDR S&P 500 ETF (SPY)
AUM62.92M
RegionNorth America
Expense Ratio0.35%
Beta0.80
IssuerStrive
Inception DateNov 10, 2022
Dividend Yield1.11%
Asset ClassEquity
Index TrackedBloomberg US 1000 Dividend Growth Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume26,850
30 Day Avg. Volume7,889
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
43.48Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering202
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
STXD Summary
The Strive 1000 Dividend Growth ETF (STXD) is an investment fund that focuses on large U.S. companies with strong potential for dividend growth. It follows the Bloomberg US 1000 Dividend Growth Index and includes well-known companies like Microsoft and Broadcom. With a mix of industries such as technology, financials, and healthcare, this ETF offers diversification and the chance to benefit from both stable income and growth. New investors might consider it for its focus on reliable, growing dividends. However, since it heavily invests in large-cap stocks, its value can fluctuate with the overall market performance.
How much will it cost me?The Strive 1000 Dividend Growth ETF (Ticker: STXD) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, aiming to select companies with strong dividend growth potential. Active management typically involves more research and decision-making, which increases costs.
What would affect this ETF?The Strive 1000 Dividend Growth ETF (STXD) could benefit from continued strength in the technology and financial sectors, which make up a significant portion of its holdings, as well as stable economic growth in the U.S., its primary geographic focus. However, rising interest rates or economic slowdowns could negatively impact dividend-paying companies, particularly in sectors like real estate and consumer cyclical, which are more sensitive to such changes. Regulatory shifts or unexpected challenges in key industries like healthcare or technology could also pose risks to the ETF's performance.
STXD Top 10 Holdings
The Strive 1000 Dividend Growth ETF leans heavily on U.S. large-cap stocks, with a notable concentration in financials and technology. Eli Lilly and Broadcom are rising stars, buoyed by strong earnings and growth in AI-related sectors, while Microsoft shows mixed signals, with cloud and AI growth offset by recent stock softness. Visa and JPMorgan are steady performers, providing stability, while Costco and Home Depot are lagging, weighed down by bearish trends and valuation concerns. Overall, the fund’s sector tilt and top holdings suggest a focus on innovation and financial resilience, but some consumer-facing names are holding it back.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Eli Lilly & Co | 5.00% | $3.15M | $976.55B | 42.34% | 72 Outperform | |
| Broadcom | 4.87% | $3.06M | $1.63T | 48.12% | 76 Outperform | |
| JPMorgan Chase | 4.78% | $3.01M | $841.89B | 19.33% | 72 Outperform | |
| Microsoft | 4.27% | $2.69M | $3.39T | 6.44% | 79 Outperform | |
| Visa | 3.15% | $1.98M | $626.74B | 2.54% | 70 Outperform | |
| Mastercard | 2.53% | $1.59M | $487.30B | 3.42% | 75 Outperform | |
| Costco | 2.42% | $1.52M | $424.67B | 2.16% | 72 Outperform | |
| AbbVie | 2.17% | $1.36M | $383.08B | 26.34% | 66 Neutral | |
| Home Depot | 2.15% | $1.35M | $377.46B | -7.37% | 66 Neutral | |
| Bank of America | 2.04% | $1.28M | $384.04B | 13.84% | 72 Outperform |
STXD Technical Analysis
Positive
―
Price Trends
37.03
Positive
36.68
Positive
35.02
Positive
Market Momentum
0.33
Negative
62.75
Neutral
79.48
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For STXD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.62, equal to the 50-day MA of 37.03, and equal to the 200-day MA of 35.02, indicating a bullish trend. The MACD of 0.33 indicates Negative momentum. The RSI at 62.75 is Neutral, neither overbought nor oversold. The STOCH value of 79.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for STXD.
STXD Peer Comparison
Comparison Results
Performance Comparison
STXD
Strive 1000 Dividend Growth ETF
38.24
5.28
16.02%
LCLG
Logan Capital Broad Innovative Growth ETF
―
―
―
MMLG
First Trust Multi-Manager Large Growth ETF
―
―
―
PRXG
Praxis Impact Large Cap Growth ETF
―
―
―
PGRO
Putnam Focused Large Cap Growth ETF
―
―
―
CGGG
Capital Group U.S. Large Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents